2017 Full & Associate Professor Appointees

Senior promotion is based on demonstrated excellence in one or more of research, creative professional activity (CPA), or teaching and service to the University. To be considered for the rank of associate professor, the candidate is required to have demonstrated a national reputation.

To be considered for the rank of full professor, the candidate is required to have demonstrated an international reputation.


Lori Albert

Albert, Lori

Lori Albert is an exceptional teacher and scholar who has made outstanding contributions to undergraduate medical education. Among her many accomplishments, she  spearheaded major revisions to the Art and Science of Clinical Medicine Year 1 and Year 2 curricula on the musculoskeletal examination, co-directed the Year 2 Mechanisms Manifestations and Management of Disease course, developed and is directing the Concepts, Patients, Communities-1 course in the new Foundations Curriculum, and created novel educational tools, including the  “Canadian Clinician’s Rheumatology Handbook,” and the “RheumExam Atlas.” A trainee notes, “Dr. Albert is a role model physician, has been prolific in introducing effective learning tools to supplement and enrich clinical teaching to residents, is an experienced educator at academic and individual levels…a caring, conscientious, hardworking and sincere individual, well-liked and respected.” Not surprisingly, Dr. Albert has received multiple teaching awards, including the prestigious W.T. Aikins Award from the Faculty of Medicine in 2008.


Mark Bayley
Physical Medicine & Rehabilitation

Bayley, Mark

Mark Bayley is a leader in neurorehabilitation following brain injury. He has conducted internationally recognized research to elucidate modifiable determinants of patterns of recovery and response to rehabilitation after brain injury and thus strategies to promote neuroplasticity (brain recovery). He developed a smartphone app to assist clinicians in personalizing their rehabilitation recommendations to stroke patients. He led the development of the Stroke Canada Optimization of Rehabilitation by Evidence (SCORE) project, which developed Canada’s first stroke rehabilitation evidence-based recommendations. He was integral to the development of guidelines for physician management of adults and children with persistent symptoms post-concussion (www.concussionsontario.org). Using health administrative databases housed at the Institute of Clinical and Evaluative Sciences (ICES), he identified gaps in concussion care, highlighting five priorities for improving post-concussion care.

Mary Bell

Bell, Mary

Mary Bell has made important contributions through her innovations in continuing professional development to advance patient-centered care and self-management for people with arthritis. She has been an ardent advocate for the translation and implementation of best-evidence for arthritis management into clinical practice in the primary care setting. She led the development and implementation of a workshop for multidisciplinary primary healthcare providers called, “Getting a Grip on Arthritis,” for which she was awarded the Dave Davis CME Research Award (2006-2008). She has previously held major administrative roles, including Director of Continuing Education and Knowledge Translation for the University of Toronto, Department of Medicine (2006-2011), and leadership in the Office of Continuing Education and Professional Development (CEPD) in the Faculty of Medicine.

Donald Branch

Branch, Donald

Donald Branch has achieved excellence in research through his scholarly contributions to immunology and virology. His work has included the study of signal transduction in cancer and infection, immune modulation and modeling of autoimmune disorders, and immune mediated interventions in HIV infection. Using mouse models of idiopathic thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AHA), his research has been important in elucidating the mechanisms of action of intravenous immunoglobulin (IVIG). Dr. Branch has been a passionate advocate for ensuring a steady pipeline of physician scientists. In 2005, he founded the Comprehensive Research Experience for Medical Students (CREMS) Program in the Faculty of Medicine; he served as CREMS director from 2004 to 2014. More than 1000 students have been involved in the CREMS Program at U of T, and similar programs have been adopted at other medical schools including McGill University and the University of Alberta.

Robert Fowler
General Internal Medicine

Fowler, Robert
Robert Fowler has made outstanding contributions through his work in the area of global infection-related critical illness and his work to support advance care planning and end of life care for the frail elderly. Dr. Fowler has led provincial and international collaborations aimed at identifying barriers to appropriate and timely access to healthcare, including during periods of system stress due to severe infectious respiratory syndrome (SARS) and pandemic influenza. He has worked with the Oxford International Severe Acute Respiratory and Emerging Infections Consortium to establish research protocols in developing countries, and published ground-breaking studies of SARS, H1N1, Ebola and MERS. He was integral to the establishment of the World Health Organization Ebola treatment guidelines. His work in West Africa was recognized in December 2015 when he was awarded the Meritorious Service Cross by the Governor General of Canada, and again in 2016 when he was awarded the Order of Ontario for his work on Ebola.

Susan Fox

Fox, Susan

Susan Fox has advanced the field of Parkinson’s disease (PD), particularly in the areas of pharmacology and pharmacotherapy, though her work to evaluate and guide evidence-based practice in movement disorders. Among her many contributions, her research has helped develop the first non-human primate model for psychosis in PD. She has elucidated a key role for serotonin (5HT) on psychosis and dyskinesia in PD. These findings have informed the development of new PD therapies, which are now being tested in clinical trials. As chair of the International Parkinson and Movement Disorder Society’s Evidence-Based Medicine Committee, she has led the development of treatment recommendations for both motor and non-motor symptoms in patients with PD. These guidelines have been used by Parkinson’s disease societies worldwide.

Shahid Husain
Infectious Diseases

Husain, Shahid
Shahid Husain has established an international reputation for his contributions to addressing infections in transplant recipients. Specifically, he has enabled physician training in the field, in addition to earlier diagnosis and improved prophylaxis, prognostication, and treatment of infections in transplant recipients. Among his contributions, he established the Transplant Infectious Diseases Fellowship Program at the University of Toronto. This unique program – the only such program worldwide –offers trainees exposure to both patients with hematological and solid organ transplants. He has also established a global consortium of 14 transplant centres to facilitate study of the epidemiology and treatment of fungal infections in lung transplant recipients.

Geoffrey Liu
Medical OncologyLiu Geoffrey

Geoffrey Liu has established a research program in cancer pharmacogenomic epidemiology directed at the discovery of biomarkers that have potential for use in precision oncology. This research ranges from cell line and xenograft models through to evaluation of human germline, serological, and tumour samples. He has been developing and validating new methods of measuring complex phenotypes, including patient-centred toxicity and symptom outcomes. Through biomarker research in both clinical trials and observational studies, Dr. Liu has identified a number of promising biomarkers that have been targeted for drug development.

Mona Loutfy
Infectious Diseases

Loutfy, Mona

Mona Loutfy has made outstanding contributions to advancing care, research and policy for HIV and women and reproductive health in Canada. In her work, she has creatively incorporated and trained ‘community’ (women and couples living with HIV) to participate as researchers. Her work has highlighted the need for supportive fertility care for Canadian women and couples with HIV seeking fertility services. In recognition of her contributions and expertise, she has been invited to join as a steering committee member for the International Workshop on HIV in Women and Girls and the European AIDS Clinical Society's Women Against Viruses in Europe (WAVE) Working Group. She was also a Guideline Development Group (GDG) member of the WHO's consolidated guideline on sexual and reproductive health and rights of women living with HIV. As an expert clinical trialist, she has taught and mentored many students in the area and has contributed to numerous pivotal clinical trials.

Bruce Perkins
Endocrinology & Metabolism

Bruce Perkins’ work to date has focused in two major areas in the field of type 1 diabetes: 1. identifying and intervening to address modifiable risk factors for complications in patients with type 1 diabetes; and 2. development of novel therapeutics for type 1 diabetes, including the artificial pancreas. He is an investigator on the Canadian Study of Longevity in Diabetes, studying physiological parameters associated with life-long protection from complications, co-principal investigator for a CIHR Strategy for Patient Oriented Research (SPOR) grant, and a member of the European Association for the Study of Diabetes’ Diabetic Neuropathy Study Group. He is also studying emerging artificial pancreas technology initiatives and has applied for three patents related to SGLT-2 inhibitors. In 2015, he was awarded the Hugh Tildesley Lectureship Award from the University of British Columbia and the Canadian Diabetes Association/CIHR Young Scientist Award.

Ramesh Prasad

Prasad, Ramesh

Ramesh Prasad has spearheaded major studies in kidney transplant recipient and donor health to guide evidence-based practice. Dr. Prasad was the first to report higher cardiovascular complication rates in South Asian kidney transplant recipients, for which he received widespread media attention. He has examined health issues faced by kidney donors, including cardiovascular disease, gout, fracture, kidney failure and economic or social impairment. He made seminal observations regarding patient outcomes related to transplant tourism and organ trafficking. His paper on the ethics of transplant commercialism was downloaded over 800 times, and was commended by the International Transplantation Society. Besides being a clinician-investigator, Dr. Prasad is also a philosopher, holding a master’s degree and presently completing his PhD in the Philosophy of Transplantation.   

Ravi Retnakaran
Endocrinology & Metabolism

Retnakaran, Ravi

Ravi Retnakaran has made major contributions to the field of diabetes through his clinical investigative studies on the pathophysiology and treatment of Type 2 Diabetes Mellitus (T2DM). His work has focused on elucidating the determinants of pancreatic beta-cell function and novel clinical strategies for its preservation in patients with, or at risk for, T2DM. In particular, his research program has (i) highlighted the potential reversibility of beta-cell dysfunction early in the course of diabetes and (ii) introduced the novel therapeutic paradigm of initial “induction therapy” to improve beta-cell function in early T2DM, followed by “maintenance therapy” aimed at preserving this beneficial effect. In 2013, Dr. Retnakaran received the Dr. Charles Hollenberg Young Investigator Award from the Canadian Society of Endocrinology and Metabolism. In 2014, he was the recipient of the Dr. Joe Doupe Young Investigator Award from the Canadian Society of Clinical Investigation. 

To be considered for the rank of associate professor, the candidate is required to have demonstrated a national reputation.

Associate Professors

Andre Amaral
Critical Care

Amaral, Andre

Andre Amaral has utilized implementation science methodologies to improve quality of care and communication in the ICU. He has been working on the development of quality metrics for critically ill patients and in establishing a community-academic collaboration to improve quality of care across Southern Ontario. His work has impacted care beyond Canada.

Eitan Amir
Medical Oncology

Amir, Eitan

Eitan Amir has advanced novel methodological approaches to the conduct of knowledge syntheses, including meta-analysis, meta-regression and analytic modeling. He has applied these novel approaches to data analyses to identify potential therapeutic targets for intervention, particularly in his field of medical oncology.

Stephen Betschel
Immunology & Allergy

Betschel, Stephen

Stephen Betschel, program director for the Division of Clinical Immunology and Allergy, has advanced care for hereditary angioedema (HAE) and adult primary immunodeficiency. He led the development of evidence based guidelines for the management of HAE and established an innovative program for the home administration of IVIG to patients with this disorder.

Andrea Boggild
Infectious Diseases

Boggild, Andrea

Andrea Boggild has made important contributions to the diagnosis and management of parasitic and neglected tropical diseases. She has served as a consultant at the provincial and national levels regarding risk of imported infections. Her work to address the appropriate evaluation and management of returning febrile travelers has garnered substantial attention and has practice changing impact.

Kelvin Chan
Medical Oncology

Chan, Kelvin
Kelvin Chan is a leader in health technology assessment, health economics, and health services research in the field of medical oncology. He has made numerous seminal contributions to cancer care, in particular through his use of systematic overviews, meta-analyses and cost-effective analyses to evaluate drug and device use.

Vinod Chandran

Chandran, Vinod

Vinod Chandran has established a program of translational research focused on psoriatic arthritis (PsA), with the goal of identifying biomarkers as well as potential therapeutic targets. As an advocate for improved care of patients with inflammatory diseases, he has spearheaded an initiative to enhance access to care for PsA patients, as well as patients with severe ocular inflammatory disease.

Chung-Wai Chow

Chow, Chung-Wai

Chung-Wai Chow studies the mechanisms responsible for chronic lung injury in the context of airway inflammation and remodeling due to inhaled toxins. She has leveraged her research findings to increase awareness of the importance of common lung diseases to the lay public, allied health professionals, policy makers and the media.

Nick Daneman
Infectious Diseases

Daneman, Nick

Nick Daneman has used his skills in clinical epidemiology to promote antimicrobial stewardship. He has established best practices for antimicrobial use for systemic bacterial infections in myriad settings, and quality improvement methodologies to move this evidence into clinical practice.

Neil Fam

Fam, Neil

Neil Fam has contributed to innovations in clinical care and residency training in the field of interventional cardiology. In particular, he has advanced the use of simulation in interventional cardiology training through the establishment of the cardiac procedural simulation lab at St. Michael’s – a University-wide training resource.

Eddy Fan
Critical Care

Fan, Eddy

Eddy Fan has made important contributions to the field of extracorporeal membrane oxygenation (ECMO) and acute respiratory distress syndrome (ARDS). He spearheaded the development of iCORE – the Toronto Intensive Care Registry and has served on an American Thoracic Society expert panel on ICU weakness.

Rajesh Gupta
General Internal Medicine

Gupta, Rajesh

Rajesh Gupta has made significant contributions through his work on substance abuse disorders. At St. Michael’s Hospital, he developed a standardized care pathway for patients hospitalized with opioid use disorders. He has also contributed through his numerous leadership and administrative roles in undergraduate medicine. 

Rashida Haq
Medical Oncology

Haq, Rashida

Rashida Haq has contributed through her innovations to clinical practice, healthcare delivery and education in medical oncology, and particularly for breast cancer survivors. In 2004, Dr. Haq established  the CIBC Breast Center – a multidisciplinary program for patients with breast cancer at St. Michael’s Hospital.

Yoo-Joung Ko
Medical Oncology


Yoo-Joung Ko has advanced the practice of genitourinary and gastrointestinal cancer care through a rigorous and innovative approach to teaching and education. Specifically, his mobile application, the Cancer mAPP, provides oncologists with direct mobile access to relevant clinical trial data to inform their clinical decision making.

Warren Lee
Critical Care

Lee, Warren

Warren Lee has conducted seminal research to elucidate the molecular mechanisms of endothelial permeability, a process relevant to diseases like acute lung injury and atherosclerosis. This work has resulted in the development of a drug to prevent vascular leak from influenza, and the awarding of a Canada Research Chair. 

Christopher Li

Li, Christopher

Christopher Li, respirology program director, has made outstanding contributions to the residency training. As a fellowship director for the University of Toronto Centre for Sleep Medicine and Circadian Biology (2007-2013), he also developed a unique, multi-disciplinary fellowship program in Sleep Medicine.

Kenneth Locke
General Internal Medicine

Locke, Kenneth

Kenneth Locke has made enormous contributions to the undergraduate medical curriculum. He established and led the Years 3 and 4 Portfolio Course and developed and implemented the highly successful “Transition to Residency” course. At the postgraduate level, he has played an important role in advancing training in ambulatory internal medicine training.

Minakshi Madan

Madan, Minakshi

Minakshi Madan is an interventional cardiologist and director of lnterventional Cardiology Clinical Trials Research at Sunnybrook Health Sciences Centre. She has made important contributions to the care of individuals with acute and established cardiovascular disease through elucidating best practice regarding interventional cardiology drugs and devices and optimal use of secondary prevention strategies.

Michael McDonald

McDonald, Michael

Michael McDonald has contributed through his roles as Director of the Advanced Heart Failure and Transplantation Fellowship Program at UHN/Toronto General Hospital, and the education director for the Toronto Transplant Institute. He established a highly successful “Principles in Immunology” foundational training course for clinical transplant fellows.  

Nazanin Meshkat
Emergency Medicine

Meshkat, Nazanin

Nazanin Meshkat was the medical lead of the first program for victims of gender-based violence in Papua New Guinea. She also played a key role in a team that established the first emergency medicine residency program in Ethiopia under the auspices of the Toronto Addis Ababa Academic Collaboration, leading to the continued expansion of much needed emergency medicine services across Ethiopia.

Matthew Muller
Infectious Diseases

Muller, Matthew

Matthew Muller is an international authority on hand hygiene, how to measure its impact on infection control outcomes and how to study compliance in a systematic way. Among his many roles, he represents infectious diseases on the Public Health Agency of Canada’s Expert Working Group on Infection Prevention and Control. 

Paul Oh
Pharmacology & Toxicology

Oh, Paul

Paul Oh is a leader in the field of cardiovascular and chronic disease prevention and rehabilitation. He has made substantial contributions to this field through his innovations in models of care, research to inform best practices, guidelines development, and teaching and education.

Jeff Perl

Perl, Jeffrey

Jeff Perl has galvanized the international community with his work to optimize the use of home peritoneal dialysis (HPD). Through his research he has demonstrated the comparative effectiveness of HPD versus various alternative treatment approaches on patient outcomes and elucidated both barriers to adoption of HPD and risk factors for survival on HPD. 

Lynfa Stroud
General Internal Medicine

Stroud, Lynfa

Lynfa Stroud is an education scholar whose research focuses on postgraduate assessment. She has developed comprehensive improvements to and conducted studies with OSCEs for both internal medicine trainees and undergraduate medical students; in addition to examining the impact of the clinical environment on assessment of resident performance.

Carmela Tartaglia

Tartaglia, Carmela

Carmela Tartaglia has established an innovative research program in FrontoTemporal Lobar Degeneration (FTLD) and post-concussion syndrome (PCS). She has investigated the role of white matter tracts in executive dysfunction in FLTD, genetic mutations in neurodegenerative disease, and biomarker to detect PCS in vivo in Canadian Football League players.

Jill Tinmouth

Tinmouth, Jill

Jill Tinmouth has developed a national and international reputation for her work on prevention of gastrointestinal malignancy, with a focus on colorectal and anal cancer. In collaboration with the Aboriginal Cancer Control Unit at Cancer Care Ontario (CCO), Dr. Tinmouth is leading a large CIHR-funded study to improve cancer screening among First Nations and Metis in Ontario.

Karen Yee

Yee, Karen
Karen Yee’s work focuses on early clinical trials to evaluate novel drug therapies, particularly those targeting molecular mutations or abnormal signaling pathways, in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Her findings have informed the development and execution of international phase III clinical trials of these therapies.

Afshan Zahedi
Endocrinology & Metabolism

Zahedi, Afshan

Afshan Zahedi has developed and supervised a highly successful Thyroid Fellowship Program at Women’s College Hospital. She has also designed and delivers continuing medical education to health professionals nationally, focused on the management of diabetes in the frail elderly.


Back to Top